RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+15.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.94B
AUM Growth
+$3.94B
(+8.1%)
Cap. Flow
+$90.3M
Cap. Flow
% of AUM
2.29%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
163
New
20
Increased
50
Reduced
30
Closed
15
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$50.5M |
| 2 |
INZY
Inozyme Pharma
INZY
|
$23.1M |
| 3 |
Kymera Therapeutics
KYMR
|
$22.9M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$21.4M |
| 5 |
Humana
HUM
|
$21.3M |
Top Sells
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$41.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$31.6M |
| 3 |
Cigna
CI
|
$30.2M |
| 4 |
Amgen
AMGN
|
$29.7M |
| 5 |
Allogene Therapeutics
ALLO
|
$18.9M |
Sector Composition
| 1 | Healthcare | 90.05% |
| 2 | Consumer Staples | 1.43% |
| 3 | Consumer Discretionary | 0.93% |
| 4 | Industrials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Phreesia
PHR
$1.81B
| $25.7M | 0.65% |
800,000
+148,500
| +23% | +$4.77M |
|
52
Mirum Pharmaceuticals
MIRM
$3.75B
| $25.6M | 0.65% |
1,327,614
+7,704
| +0.6% | +$148K |
|
53
Bright Horizons
BFAM
$6.62B
| $25.2M | 0.64% |
165,500
+67,000
| +68% | +$10.2M |
|
54
Galapagos
GLPG
$2.06B
| $24.8M | 0.63% |
175,000
| – | – |
|
55
Collegium Pharmaceutical
COLL
$1.25B
| $24.5M | 0.62% |
1,175,000
| – | – |
|
56
Assembly Biosciences
ASMB
$183M
| $24.1M | 0.61% |
1,463,915
-35,000
| -2% | -$575K |
|
|
INZY
57
DELISTED
Inozyme Pharma
INZY
| $23.1M | 0.59% |
+879,954
| New | +$23.1M |
|
|
58
Kymera Therapeutics
KYMR
$3.1B
| $22.9M | 0.58% |
+709,965
| New | +$22.9M |
|
59
Acadia Healthcare
ACHC
$2.15B
| $22.4M | 0.57% |
760,000
-140,000
| -16% | -$4.13M |
|
60
Guardant Health
GH
$8.11B
| $21.2M | 0.54% |
190,000
| – | – |
|
|
MNTA
61
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $21M | 0.53% |
400,000
| – | – |
|
62
Applied Therapeutics
APLT
$73.7M
| $20.6M | 0.52% |
991,573
| – | – |
|
63
Royalty Pharma
RPRX
$15.8B
| $20.4M | 0.52% |
485,000
-15,000
| -3% | -$631K |
|
64
Athira Pharma
ATHA
$15.5M
| $20.4M | 0.52% |
+1,102,702
| New | +$20.4M |
|
|
ALLK
65
DELISTED
Allakos
ALLK
| $19.7M | 0.5% |
241,582
+2,550
| +1% | +$208K |
|
66
NovoCure
NVCR
$1.35B
| $19.5M | 0.49% |
175,000
| – | – |
|
|
PPD
67
DELISTED
PPD, Inc. Common Stock
PPD
| $19.4M | 0.49% |
525,000
+37,500
| +8% | +$1.39M |
|
68
Travere Therapeutics
TVTX
$1.75B
| $18.9M | 0.48% |
1,024,261
| – | – |
|
|
KRTX
69
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $18.9M | 0.48% |
244,106
+40,794
| +20% | +$3.15M |
|
70
HealthEquity
HQY
$8.26B
| $18.5M | 0.47% |
360,100
+40,000
| +12% | +$2.05M |
|
71
Compugen
CGEN
$133M
| $18.4M | 0.47% |
1,132,775
+2,400
| +0.2% | +$39K |
|
|
AMRN
72
Amarin Corp
AMRN
$311M
| $18.3M | 0.46% |
4,350,000
-300,000
| -6% | -$1.26M |
|
73
TG Therapeutics
TGTX
$5.03B
| $18.3M | 0.46% |
682,926
| – | – |
|
74
Relay Therapeutics
RLAY
$709M
| $17.6M | 0.45% |
+413,674
| New | +$17.6M |
|
|
SWAV
75
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $16.7M | 0.42% |
220,000
+22,500
| +11% | +$1.71M |
|